"Prof. Christopher Huber". Biontech Biography. Biontech. Retrieved 5 August 2021. "SEC Filing | BioNTech". investors.biontech.de. p. 130. Retrieved 28 December...

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...

at BioNTech's laboratories in Mainz, Germany, just days after the SARS-Cov-2 genetic sequence was first made public. In September 2020, BioNTech received...

Pfizer–BioNTech's BNT162b2 COVID-19 vaccine for widespread use. On 11 December, the FDA gave emergency use authorization for the Pfizer–BioNTech COVID-19...

delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine." By the end of September, Canada will receive the 40 million Pfizer-BioNTech doses. Major General Fortin...

approved the Pfizer-BioNTech vaccine for section 21 Emergency Use Authorisation. A trial ending in March 2021 of the Pfizer-BioNTech's COVID-19 vaccine appeared...

regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin...

On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional...

Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later...

Bank to address the health and economic impact of COVID-19. Meanwhile, BioNTech and the European Union are collaborating to assess mRNA vaccine production...